Literature DB >> 3311661

Effects of oral cisapride on interdigestive jejunal motor activity, psychomotor function, and side-effect profile in healthy man.

G Stacher1, G Gaupmann, G Mittelbach, C Schneider, H Steinringer, B Langer.   

Abstract

Intravenous cisapride was shown to induce a phase-2-like pattern of human interdigestive jejunal motor activity containing an increased number of propagated contractions. This study investigated the effects of oral cisapride in 12 fasting healthy males. Jejunal pressures were recorded by a pneumohydraulic system and five catheter orifices positioned 10-30 cm aborad the ligament of Treitz. Single oral doses of 5 and 10 mg cisapride, administered 5 min after an activity front under random double-blind conditions, induced a phase-2-like jejunal motor pattern with a significantly higher number and amplitude of contractions and significantly more aborally propagated waves than placebo (P less than 0.001), while the number of subjects with activity fronts decreased with increasing dose. Five and 10 mg cisapride administered tid for three days affected psychomotor function, subjective feelings, and side-effect frequency, apart from increases in systolic blood pressure and heart rate, no more than placebo. It is concluded that in fasting man, oral cisapride induces a highly propagative phase-2-like jejunal motor pattern causing only minor side effects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311661     DOI: 10.1007/BF01296370

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  10 in total

1.  The propagation of segmental contractions along the small intestine.

Authors:  M L Grivel; Y Ruckebusch
Journal:  J Physiol       Date:  1972-12       Impact factor: 5.182

2.  Relationship of motility to flow of contents in the human small intestine.

Authors:  P Kerlin; A Zinsmeister; S Phillips
Journal:  Gastroenterology       Date:  1982-04       Impact factor: 22.682

3.  Minute rhythm of electrical spike bursts of the small intestine in different species.

Authors:  P Fleckenstein; L Bueno; J Fioramonti; Y Ruckebusch
Journal:  Am J Physiol       Date:  1982-06

Review 4.  Psychomotor function and psychoactive drugs.

Authors:  I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

5.  Migrating electrical spike activity in the fasting human small intestine.

Authors:  P Fleckenstein
Journal:  Am J Dig Dis       Date:  1978-09

6.  Rate of flow of digesta and electrical activity of the small intestine in dogs and sheep.

Authors:  L Bueno; J Fioramonti; Y Ruckebusch
Journal:  J Physiol       Date:  1975-07       Impact factor: 5.182

7.  Ceruletide increases dose dependently both jejunal motor activity and threshold and tolerance to experimentally induced pain in healthy man.

Authors:  G Stacher; H Steinringer; G Schmierer; C Schneider; S Winklehner; G Mittelbach; C De Paolis; C Praga
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

8.  Effects of cisapride on jejunal motor activity in fasting healthy humans.

Authors:  G Stacher; H Steinringer; C Schneider; S Winklehner; G Mittelbach; G Gaupmann
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

9.  Measurement of gastric emptying in dyspeptic patients: effect of a new gastrokinetic agent (cisapride).

Authors:  R Jian; F Ducrot; C Piedeloup; J Y Mary; Y Najean; J J Bernier
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

10.  Electrical spike activity in the human small intestine. A multiple electrode study of fasting diurnal variations.

Authors:  P Fleckenstein; A Oigaard
Journal:  Am J Dig Dis       Date:  1978-09
  10 in total
  11 in total

Review 1.  Mechanisms of cisapride affecting gallbladder motility.

Authors:  R von Kiedrowski; S Huijghebaert; R Raedsch
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

2.  Effects of a 5-hydroxytryptamine3 receptor antagonist (ICS 205-930) on colonic motor activity in healthy men.

Authors:  G Stacher; G Gaupmann; C Schneider; G Stacher-Janotta; G Steiner-Mittelbach; T A Abatzi; H Steinringer
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

3.  Longterm oral cisapride improves interdigestive antroduodenal motility in dyspeptic patients.

Authors:  P A Testoni; F Bagnolo; L Fanti; S Passaretti; A Tittobello
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

Review 4.  Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.

Authors:  R W McCallum; C Prakash; D M Campoli-Richards; K L Goa
Journal:  Drugs       Date:  1988-12       Impact factor: 9.546

5.  [Motility disorders in the blind loop after Roux-en-y reconstruction. Electromyography studies in the animal experiment].

Authors:  E Schippers; V Schumpelick
Journal:  Langenbecks Arch Chir       Date:  1994

6.  Effects of cisapride on gastric emptying of oil and aqueous meal components, hunger, and fullness.

Authors:  K L Jones; M Horowitz; B I Carney; W M Sun; B E Chatterton
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

7.  Acid, motility, and ulcers: a comparison of cisapride with placebo in the prevention of duodenal ulcer relapse.

Authors:  D D Kerrigan; M E Taylor; N W Read; A G Johnson
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

8.  Assessment by prolonged ambulatory manometry of the effect of oral cisapride on proximal small bowel inter-digestive motility.

Authors:  M J Benson; F D Castillo; J J Deeks; D L Wingate
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

9.  Effects of cisapride on postcibal jejunal motor activity.

Authors:  G Stacher; G Gaupmann; H Steinringer; C Schneider; G Stacher-Janotta; G Steiner-Mittelbach; T A Abatzi
Journal:  Dig Dis Sci       Date:  1989-09       Impact factor: 3.199

Review 10.  Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders.

Authors:  J Tack; M Camilleri; L Chang; W D Chey; J J Galligan; B E Lacy; S Müller-Lissner; E M M Quigley; J Schuurkes; J H De Maeyer; V Stanghellini
Journal:  Aliment Pharmacol Ther       Date:  2012-02-22       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.